Cornbread Hemp Secures Key Spot in Medicare CBD Rollout

Kentucky-based Cornbread Hemp has secured an exclusive supply contract with Alliant Purchasing, a national group purchasing organization (GPO) that negotiates pricing and procurement for a network that spans 68,000 provider locations. The agreement gives Cornbread Hemp a direct distribution pathway into the system that those providers use to source clinical products.

The contract comes as Medicare prepares to launch its first cannabinoid initiative for seniors. The pilot is being administered by the Centers for Medicare and Medicaid Innovation (CMMI), the office responsible for testing new care models designed to improve outcomes and reduce costs. Beginning April 1, participating accountable care organizations will be able to furnish up to $500 in full-spectrum CBD products per patient per year when physicians believe the products may help reduce downstream healthcare spending.

Cornbread’s Role in the Medicare Pilot

“Cornbread Hemp was built on a simple conviction: that clean, organic, rigorously tested hemp products can meaningfully improve people’s lives,” Eric Zipperle, co‑founder and CEO of Cornbread Hemp, said in a March 25 release about the contract. “The CMMI pilot is the most important moment in the history of the hemp industry, and we believe Cornbread is uniquely positioned to serve it. We have the certifications, the infrastructure, the brand reputation, and the category expertise to deliver for Medicare beneficiaries who deserve access to the best hemp products America produces.”

Alliant Purchasing’s clinical leadership framed the partnership as part of a broader shift in how providers are evaluating alternative wellness options.

“Cornbread Hemp provides alternative wellness solutions that support restorative sleep, alleviate stress and anxiety, and offer effective pain management for those seeking non‑narcotic or more natural, organic options,” said Brandy Fehrenbach, RN, BSN, chief clinical officer at Alliant Purchasing. “As the healthcare and legislative landscapes evolve, these products are increasingly being integrated into clinical discussions at the provider level across many states. We are excited to align with a partner that shares our deep commitment to prioritizing patient outcomes and holistic care.”

In an interview with IgniteIt.com, Cornbread Hemp co-founder and chief communications officer Jim Higdon called the moment “extraordinary” and said the company sees the pilot as a turning point in the federal government’s relationship with THC and full-spectrum hemp products.

“We are participating in a historic pilot program that is going to revolutionize the federal government’s relationship with THC,” Higdon said. “We have gone from throwing people in prison for THC to understanding its therapeutic value and facilitating patient access.”

What the Pilot Could Mean for Seniors

Higdon said the Alliant contract gives Cornbread a direct route into the institutional procurement systems used by the Accountable Care Organizations participating in the pilot. Those organizations have not yet been publicly identified, but he expects them to be announced as the program launches.

He added that the pilot’s clinical structure could generate meaningful insights into how cannabinoids interact with common medications and how they may help reduce reliance on certain prescriptions. Doctors are incentivized to furnish CBD, he said, because they believe it may help keep patients healthier for less.

“If CBD products help a patient take less medication, that is good for the patient, and it is good for the hospital company,” Higdon said. “It is good for everybody in the system because we are keeping patients healthier for less. That is the thesis of this pilot program.”

A Federal Pilot Collides With a Federal Ban

But the pilot is unfolding alongside a contradictory federal policy. While the executive branch has authorized the use of full-spectrum CBD products for Medicare beneficiaries, Congress has already scheduled a federal hemp ban for November that would make many of those same products illegal.

“The executive branch’s desire for these products to be legal for the Medicare pilot does not make them legal,” Higdon said. “Congress has declared that these products will become illegal this November.”

Cornbread Hemp is working with the U.S. Hemp Roundtable and other trade groups to persuade lawmakers to align federal statute with the administration’s position before the deadline. 

“If we cannot change the law by November, then all this is for naught,” Higdon said. “Everything that the Medicare program has set up to accomplish will fail.”

For now, the company is preparing for April 1 while navigating a fast‑moving policy environment.

“No one knows how this is going to work, and we are in the process of figuring that out,” said Higdon.